22 research outputs found
Recommended from our members
Research and Design of a Routing Protocol in Large-Scale Wireless Sensor Networks
无线传感器网络,作为全球未来十大技术之一,集成了传感器技术、嵌入式计算技术、分布式信息处理和自组织网技术,可实时感知、采集、处理、传输网络分布区域内的各种信息数据,在军事国防、生物医疗、环境监测、抢险救灾、防恐反恐、危险区域远程控制等领域具有十分广阔的应用前景。 本文研究分析了无线传感器网络的已有路由协议,并针对大规模的无线传感器网络设计了一种树状路由协议,它根据节点地址信息来形成路由,从而简化了复杂繁冗的路由表查找和维护,节省了不必要的开销,提高了路由效率,实现了快速有效的数据传输。 为支持此路由协议本文提出了一种自适应动态地址分配算——ADAR(AdaptiveDynamicAddre...As one of the ten high technologies in the future, wireless sensor network, which is the integration of micro-sensors, embedded computing, modern network and Ad Hoc technologies, can apperceive, collect, process and transmit various information data within the region. It can be used in military defense, biomedical, environmental monitoring, disaster relief, counter-terrorism, remote control of haz...学位:工学硕士院系专业:信息科学与技术学院通信工程系_通信与信息系统学号:2332007115216
Impaired mitochondrial maturation of sulfite oxidase in a patient with severe sulfite oxidase deficiency
Sulfite oxidase (SO) is encoded by the nuclear SUOX gene and catalyzes the final step in cysteine catabolism thereby oxidizing sulfite to sulfate. Oxidation of sulfite is dependent on two cofactors within SO, a heme and the molybdenum cofactor (Moco), the latter forming the catalytic site of sulfite oxidation. SO localizes to the intermembrane space of mitochondria where both-pre-SO processing and cofactor insertion-are essential steps during SO maturation. Isolated SO deficiency (iSOD) is a rare inborn error of metabolism caused by mutations in the SUOX gene that lead to non-functional SO. ISOD is characterized by rapidly progressive neurodegeneration and death in early infancy. We diagnosed an iSOD patient with homozygous mutation of SUOX at c.1084G>A replacing Gly362 to serine. To understand the mechanism of disease, we expressed patient-derived G362S SO in Escherichia coli and surprisingly found full catalytic activity, while in patient fibroblasts no SO activity was detected, suggesting differences between bacterial and human expression. Moco reconstitution of apo-G362S SO was found to be approximately 90-fold reduced in comparison to apo-WT SO in vitro. In line, levels of SO-bound Moco in cells overexpressing G362S SO were significantly reduced compared to cells expressing WT SO providing evidence for compromised maturation of G362S SO in cellulo. Addition of molybdate to culture medium partially rescued impaired Moco binding of G362S SO and restored SO activity in patient fibroblasts. Thus, this study demonstrates the importance of the orchestrated maturation of SO and provides a first case of Moco-responsive iSOD
Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need
The subject of colorectal neuroendocrine neoplasms (NENs), subdivided
into well-differentiated NENs, termed neuroendocrine tumours (NETs;
grade (G) 1 and 2), and poorly differentiated NENs, termed
neuroendocrine carcinomas (NECs; G3) according to the 2010 World Health
Organisation (WHO) classification, has arguably not had as much
attention or study as NENs occurring in other sites. Colorectal NETs and
NECs are however easier to study than many others since they are usually
not difficult to remove and are increasingly detected because of
intensified colorectal cancer screening and surveillance programmes.
Colorectal NETs and NECs show site-specific heterogeneity with variable
behaviour and different therapeutic options; these various aspects
provide unique challenges. Because of bowel cancer screening programmes,
colorectal NENs, like conventional adenocarcinomas, may be diagnosed at
a stage that is associated with improved survival. In this article we
intend to describe and define areas of unmet needs relating to the
epidemiology, classification, pathology, diagnosis and therapy of
colorectal NETs (including NETs G3), colorectal NECs, and finally, mixed
adeno-neuroendocrine carcinomas (MANECs) by reviewing and discussing the
relevant literature
Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms
Recently, the European Neuroendocrine Tumor Society (ENETS) held working
sessions composed of members of the advisory board and other
neuroendocrine neoplasm (NEN) experts to attempt to identify unmet needs
in NENs in different locations or with advanced/poorly differentiated
NENs. This report briefly summarizes the main proposed areas of unmet
needs in patients with functional and nonfunctional pancreatic NENs